Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-24-001964
Filing Date
2024-11-14
Accepted
2024-11-14 13:28:32
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 apls13gasep24.txt SC 13G/A 5139
  Complete submission text file 0001897612-24-001964.txt   6662
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13G/A